Skip to content
Inciteful Med

Standard of Care: Managing Acute Episodes and Daily Health

Last updated:

MELAS management focuses on optimizing energy and minimizing metabolic crises. Acute stroke-like episodes are emergencies treated with IV L-arginine. Daily care requires a 'mitochondrial cocktail' of supplements, steady nutrition, and strictly avoiding toxic medications like valproic acid.

Key Takeaways

  • • Acute stroke-like episodes are medical emergencies requiring immediate treatment with intravenous L-arginine to restore brain blood flow.
  • • Certain medications, including valproic acid and Lactated Ringer's solution, are highly toxic to patients with MELAS and must be strictly avoided.
  • • A daily mitochondrial cocktail including CoQ10, L-carnitine, and B vitamins is recommended to support cellular energy production.
  • • Oral L-arginine or L-citrulline is taken daily to maintain nitric oxide levels and help prevent future stroke-like episodes.
  • • Ordinary physical stressors like fasting, fever, or infection can trigger a dangerous metabolic crisis and require proactive management.

Because MELAS is a complex condition that affects how every cell produces energy, management requires a specialized approach. There is currently no cure, but the goal of treatment is to optimize energy production, support the brain and muscles, and reduce the frequency of “energy crises” like stroke-like episodes [1][2].

Managing Acute Stroke-Like Episodes (SLEs)

When a stroke-like episode occurs, it is considered a medical emergency. Unlike a typical stroke, the focus is on restoring the energy balance in the brain and improving blood flow to the smallest vessels [2][3].

  • L-arginine (The NO Booster): People with MELAS often have a deficiency in nitric oxide (NO), a molecule that helps blood vessels relax and stay open [3][4]. During an acute SLE, doctors may use high-dose intravenous (IV) L-arginine (typically 0.5 g/kg/day) to boost NO levels and improve blood flow to the brain [5][2].
  • Seizure Control: Since seizures are a major consumer of energy and can trigger or worsen an SLE, stopping them quickly is a top priority in acute care [6][7].

Medications to Avoid or Use Cautiously

Because damaged mitochondria are incredibly fragile, some common medications can cause severe harm. It is highly recommended to carry an Emergency ER Wallet Card that lists your diagnosis and contraindicated medications, as ER staff may not be familiar with MELAS protocols.

  • Avoid Valproic Acid (Depakote): Often used for seizures, this drug is highly toxic to mitochondria and can interfere with how the body processes fats for energy, worsening the disease [8][1]. Safer seizure alternatives include Levetiracetam (Keppra) [9][10].
  • Use Metformin Cautiously: Metformin is a common diabetes medication. Because people with MELAS are at high risk for diabetes, it may be prescribed, but it carries a severe risk of drastically increasing lactic acid buildup [11][12].
  • Avoid Lactated Ringer’s (LR) Solution: NEVER use Lactated Ringer’s for IV fluids. Administering LR to a patient already struggling with mitochondrial dysfunction can dangerously exacerbate lactic acidosis.
  • Anesthesia Sensitivity: Patients with MELAS are highly sensitive to anesthesia. Prolonged use of anesthetics like propofol can trigger a metabolic crisis known as Propofol Infusion Syndrome (PRIS). Always consult a specialist before surgery.

The ‘Mitochondrial Cocktail’

The “mitochondrial cocktail” is a combination of supplements used daily to support energy metabolism. While evidence from large clinical trials is limited, many specialists recommend these supplements because they provide the “raw materials” mitochondria need to function [13][14].

  1. Coenzyme Q10 (CoQ10): Helps move electrons through the energy-making chain [13].
  2. L-carnitine: Assists in moving fatty acids into the mitochondria to be burned for fuel [14].
  3. B Vitamins (B1, B2, Biotin): Act as essential “helpers” (cofactors) for various metabolic enzymes [13][15].
  4. L-arginine or L-citrulline: Taken daily in oral form to maintain healthy nitric oxide levels and prevent future SLEs [16][5]. L-citrulline is sometimes preferred because the body can absorb it more easily than L-arginine [17][18].

Managing Stress and Illness

Ordinary stressors—like a fever, infection, or surgery—can push a patient into a metabolic crisis [19].

  • Hydration: Maintaining fluids is critical, often with IV fluids containing dextrose (sugar) to provide the cells with a quick source of energy [19][20]. (Remember: No Lactated Ringer’s).
  • Avoid Fasting: Prolonged periods without food can force the body to rely on damaged energy pathways, so consistent nutrition is important [21].
  • Temperature Control: Managing fevers quickly with acetaminophen (Tylenol) is vital to keep the body’s metabolic rate from spiking [15].

Always consult with a mitochondrial specialist before starting any supplements or changing medications. To ensure you are managing all aspects of the disease, read about Protecting Your Whole Body: Multisystem Care and Monitoring.

Frequently Asked Questions

How are stroke-like episodes in MELAS treated?
Stroke-like episodes in MELAS are considered a medical emergency and are treated differently than typical strokes. Doctors primarily use high-dose intravenous (IV) L-arginine to boost nitric oxide levels, which relaxes blood vessels and restores vital blood flow to the brain.
What medications should be avoided if you have MELAS?
Patients with MELAS must avoid several common medications that are toxic to fragile mitochondria. Valproic acid (Depakote), Lactated Ringer's IV fluids, and certain anesthetics like propofol should be strictly avoided, while metformin must be used with extreme caution.
What is the mitochondrial cocktail for MELAS?
The mitochondrial cocktail is a daily combination of supplements designed to provide the raw materials your cells need to produce energy. It typically includes Coenzyme Q10, L-carnitine, B vitamins, and oral L-arginine or L-citrulline.
Can L-citrulline be used instead of L-arginine for MELAS?
Yes, L-citrulline is often used as a daily maintenance alternative to L-arginine because the body can absorb it more easily. Both supplements help maintain healthy nitric oxide levels to keep blood vessels open and prevent future stroke-like episodes.
Why is fasting dangerous for someone with MELAS?
Prolonged periods without food force the body to rely on damaged energy pathways, which can easily trigger a dangerous metabolic crisis. Consistent nutrition and hydration are critical to maintaining stable energy levels and protecting the brain and muscles.

Questions for Your Doctor

  • • If a stroke-like episode begins, do we have a protocol for starting high-dose IV L-arginine immediately?
  • • What is the target plasma arginine level we should aim for with daily maintenance therapy?
  • • Is L-citrulline an option for us if oral L-arginine is difficult to tolerate?
  • • During a common illness like the flu, should we adjust the 'mitochondrial cocktail' or increase fluid intake to prevent a metabolic crisis?
  • • Can you help us draft an 'Emergency Wallet Card' to present at the ER to avoid contraindicated medications?

Questions for You

  • • How well am I (or my child) tolerating the daily supplements, and are there any side effects like stomach upset?
  • • Am I keeping a list of 'safe' and 'unsafe' medications to share with any new doctors or emergency room staff?
  • • Have I noticed a difference in energy levels or the frequency of 'brain fog' since starting the mitochondrial cocktail?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.

    Fan HC, Lee HF, Yue CT, Chi CS

    Life (Basel, Switzerland) 2021; (11(11)) doi:10.3390/life11111111.

    PMID: 34832987
  2. 2

    MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.

    El-Hattab AW, Adesina AM, Jones J, Scaglia F

    Molecular genetics and metabolism 2015; (116(1-2)):4-12.

    PMID: 26095523
  3. 3

    Arginine and citrulline for the treatment of MELAS syndrome.

    El-Hattab AW, Almannai M, Scaglia F

    Journal of inborn errors of metabolism and screening 2017; (5()) doi:10.1177/2326409817697399.

    PMID: 28736735
  4. 4

    Assessment of Nitric Oxide Production in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome with the Use of a Stable Isotope Tracer Infusion Technique.

    El-Hattab AW, Jahoor F

    The Journal of nutrition 2017; (147(7)):1251-1257 doi:10.3945/jn.117.248435.

    PMID: 28515163
  5. 5

    Reversal of Stroke-Like Episodes With L-Arginine and Meticulous Perioperative Management of Renal Transplantation in a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome. Case Report.

    Al Yazidi G, Mulder J, Licht C, et al.

    The Neurohospitalist 2022; (12(1)):67-73 doi:10.1177/19418744211000512.

    PMID: 34950389
  6. 6

    Mitochondrial Strokes: Diagnostic Challenges and Chameleons.

    Pizzamiglio C, Bugiardini E, Macken WL, et al.

    Genes 2021; (12(10)) doi:10.3390/genes12101643.

    PMID: 34681037
  7. 7

    Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options.

    Fryer RH, Bain JM, De Vivo DC

    Pediatric neurology 2016; (56()):59-61 doi:10.1016/j.pediatrneurol.2015.12.010.

    PMID: 26797286
  8. 8

    Epilepsy Associated With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.

    Li J, Zhang W, Cui Z, et al.

    Frontiers in neurology 2021; (12()):675816 doi:10.3389/fneur.2021.675816.

    PMID: 34177782
  9. 9

    Fahr Syndrome, Hypoparathyroidism and Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome.

    Li J, Wang X, Guo Y, et al.

    AACE endocrinology and diabetes 2026; (13(1)):102-106 doi:10.1016/j.aed.2025.09.007.

    PMID: 41641297
  10. 10

    Effective Management of Chronic Intestinal Pseudo-Obstruction in MELAS Using Acotiamide: A Case Report.

    Kawano Y, Taniguchi A, Narita Y, et al.

    Case reports in neurology 2024; (16(1)):288-293 doi:10.1159/000541012.

    PMID: 39544351
  11. 11

    Neurological manifestations in m.3243A>G-related disease triggered by metformin.

    Tong HF, Lee HH, Tong TT, et al.

    Journal of diabetes and its complications 2022; (36(3)):108111 doi:10.1016/j.jdiacomp.2021.108111.

    PMID: 35123869
  12. 12

    Safe Use of Metformin in Mitochondrial Diabetes in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes: Insights From a Patient With m.3243A>G Mutation.

    Santhosh T, Ramamurthy P, Simha V

    AACE endocrinology and diabetes 2025; (12(3)):150-152 doi:10.1016/j.aed.2025.07.001.

    PMID: 41048693
  13. 13

    Two Patients Diagnosed as Succinate Dehydrogenase Deficiency: Case Report.

    Ürey BC, Ceylan AC, Çavdarlı B, et al.

    Molecular syndromology 2023; (14(2)):171-174 doi:10.1159/000527538.

    PMID: 37064335
  14. 14

    Diagnosing Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Syndrome in a Young Adult Female Patient With Seizures and Lactic Acidosis.

    Sane IA, Gupte JR

    Cureus 2025; (17(7)):e88031 doi:10.7759/cureus.88031.

    PMID: 40821128
  15. 15

    Efficacy of a mitochondrial drug cocktail in preventing acute encephalopathy with biphasic seizures and late reduced diffusion.

    Omata T, Aoyama H, Murayama K, et al.

    Journal of the neurological sciences 2024; (466()):123245 doi:10.1016/j.jns.2024.123245.

    PMID: 39303350
  16. 16

    Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

    Ikawa M, Povalko N, Koga Y

    Current opinion in clinical nutrition and metabolic care 2020; (23(1)):17-22 doi:10.1097/MCO.0000000000000610.

    PMID: 31693521
  17. 17

    Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation.

    El-Hattab AW, Emrick LT, Hsu JW, et al.

    Molecular genetics and metabolism 2016; (117(4)):407-12.

    PMID: 26851065
  18. 18

    Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review.

    Rashid J, Kumar SS, Job KM, et al.

    Paediatric drugs 2020; (22(3)):279-293 doi:10.1007/s40272-020-00384-5.

    PMID: 32140997
  19. 19

    ECMO for Metabolic Crisis in a Patient with Mitochondrial Disease.

    Sharma S, Deerman C, Andreae MH, Myler C

    Case reports in anesthesiology 2021; (2021()):9914311 doi:10.1155/2021/9914311.

    PMID: 34760322
  20. 20

    Pearls & Oy-sters: Whole-Genome Sequencing in Critically Ill Neurologic Patient Leads to Diagnosis With Treatment Implications.

    Gaillard JR, Whitt Z, Selwa LM, et al.

    Neurology 2023; (101(13)):588-592 doi:10.1212/WNL.0000000000207552.

    PMID: 37460236
  21. 21

    One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.

    Esterhuizen K, Lindeque JZ, Mason S, et al.

    Metabolomics : Official journal of the Metabolomic Society 2021; (17(1)):10 doi:10.1007/s11306-020-01769-w.

    PMID: 33438095

This page provides educational information about managing MELAS and does not constitute medical advice. Always consult your mitochondrial specialist or healthcare provider before altering medications or supplements.

Stay up to date

Get notified when new research about MELAS is published.

No spam. Unsubscribe anytime.